Aakaar Medical Technologies Ltd. (NSE:AAKAAR)
63.80
-3.35 (-4.99%)
At close: Oct 23, 2026
NSE:AAKAAR Revenue
In the fiscal year ending March 31, 2026, Aakaar Medical Technologies had annual revenue of 669.64M INR with 8.74% growth. Aakaar Medical Technologies had revenue of 416.39M in the half year ending March 31, 2026. That makes Aakaar Medical Technologies the 38,753rd largest company in the world by revenue and 3,538th in India.
Revenue
669.64M
Revenue Growth
+8.74%
P/S Ratio
1.35
Revenue / Employee
2.50M
Employees
268
Market Cap
904.23M
Revenue by Segment
- Aesthetic Products 596.08M 89.0%
- Aesthetic Devices & Device Consumables 73.57M 11.0%
Fiscal year ended Mar 31, 2026 See the full NSE:AAKAAR breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 669.64M | 53.81M | 8.74% |
| Mar 31, 2025 | 615.83M | 154.72M | 33.55% |
| Mar 31, 2024 | 461.11M | 133.26M | 40.65% |
| Mar 31, 2023 | 327.85M | 133.19M | 68.43% |
| Mar 31, 2022 | 194.65M | 70.27M | 56.50% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Emami | 39.15B |
| Bajaj Consumer Care | 13.00B |
| Tiaan Consumer | 8.28B |
| Anondita Medicare | 1.37B |
| Recode Studios | 799.50M |
| MFL India | 652.28M |
| Ravelcare | 269.54M |
| Paramount Cosmetics (India) | 200.80M |